Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders

[1]  Kris Dierickx,et al.  To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts , 2012, European Journal of Human Genetics.

[2]  Simona Soverini,et al.  Comparison of Next-Generation Sequencing Systems , 2013 .

[3]  H. C. Fan,et al.  Erratum: Non-invasive prenatal measurement of the fetal genome , 2012, Nature.

[4]  Y. Lo,et al.  Genomic analysis of fetal nucleic acids in maternal blood. , 2012, Annual review of genomics and human genetics.

[5]  J. Vermeesch,et al.  The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe , 2012, European Journal of Human Genetics.

[6]  Zlatko Trajanoski,et al.  SIMPLEX: Cloud-Enabled Pipeline for the Comprehensive Analysis of Exome Sequencing Data , 2012, PloS one.

[7]  Jacqueline A Palace,et al.  Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. , 2012, American journal of human genetics.

[8]  E. Leshinsky‐Silver,et al.  Samaritan myopathy, an ultimately benign congenital myopathy, is caused by a RYR1 mutation , 2012, Acta Neuropathologica.

[9]  Hong Li,et al.  [Application of next-generation sequencing technology for genetic diagnosis of Duchenne muscular dystrophy]. , 2012, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[10]  A N Desai,et al.  Next‐generation sequencing: ready for the clinics? , 2012, Clinical genetics.

[11]  M. Santibanez-Koref,et al.  Titin mutation segregates with hereditary myopathy with early respiratory failure. , 2012, Brain : a journal of neurology.

[12]  K. Nowak.  Trusting new age weapons to tackle titin. , 2012, Brain : a journal of neurology.

[13]  B. Brådvik,et al.  Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. , 2012, Brain : a journal of neurology.

[14]  A. Pestronk,et al.  Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy , 2012, Neurology.

[15]  Christian Gilissen,et al.  Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.

[16]  T. Dallman,et al.  Performance comparison of benchtop high-throughput sequencing platforms , 2012, Nature Biotechnology.

[17]  Nasim Vasli,et al.  Next generation sequencing for molecular diagnosis of neuromuscular diseases , 2012, Acta Neuropathologica.

[18]  S. Edvardson,et al.  Hereditary sensory autonomic neuropathy caused by a mutation in dystonin , 2012, Annals of Neurology.

[19]  N. Laing.  Genetics of neuromuscular disorders , 2012, Critical reviews in clinical laboratory sciences.

[20]  I. Nonaka,et al.  Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalomoplegia identified through massively parallel sequencing , 2012, American journal of medical genetics. Part A.

[21]  Yan Huang,et al.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia , 2012, Human mutation.

[22]  M. García-Villanueva,et al.  Autosomal recessive Emery–Dreifuss muscular dystrophy caused by a novel mutation (R225Q) in the lamin A/C gene identified by exome sequencing , 2012, Muscle & nerve.

[23]  C. Barnes,et al.  SMN1 gene duplications are associated with sporadic ALS , 2012, Neurology.

[24]  J. Dowling,et al.  Congenital Myopathies: An Update , 2012, Current Neurology and Neuroscience Reports.

[25]  A. Pestronk,et al.  Exome sequencing reveals DNAJB6 mutations in dominantly‐inherited myopathy , 2012, Annals of neurology.

[26]  A. Goris,et al.  Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis , 2012, Human molecular genetics.

[27]  Stanley F. Nelson,et al.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study , 2012, Genetics in Medicine.

[28]  Michael T. Ryan,et al.  Next‐generation sequencing in molecular diagnosis: NUBPL mutations highlight the challenges of variant detection and interpretation , 2012, Human mutation.

[29]  N. Lévy,et al.  Validation of comparative genomic hybridization arrays for the detection of genomic rearrangements of the calpain‐3 and dysferlin genes , 2012, Clinical genetics.

[30]  D. Cooper,et al.  Exome sequencing: Dual role as a discovery and diagnostic tool , 2012, Annals of neurology.

[31]  J. Dungan,et al.  Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing , 2012 .

[32]  W. Krysa,et al.  Rapid detection of large expansions in progressive myoclonus epilepsy type 1, myotonic dystrophy type 2 and spinocerebellar ataxia type 8. , 2012, Neurologia i neurochirurgia polska.

[33]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[34]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[35]  Seungbok Lee,et al.  Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform , 2011, Journal of Medical Genetics.

[36]  Hugo Y. K. Lam,et al.  Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.

[37]  Raymond K. Auerbach,et al.  The real cost of sequencing: higher than you think! , 2011, Genome Biology.

[38]  Bernard P. Puc,et al.  An integrated semiconductor device enabling non-optical genome sequencing , 2011, Nature.

[39]  Stephan Züchner,et al.  Exome sequencing allows for rapid gene identification in a Charcot‐Marie‐Tooth family , 2011, Annals of neurology.

[40]  A. Verma.  Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies , 2011 .

[41]  C. Minetti,et al.  Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. , 2011, Handbook of clinical neurology.

[42]  Huanming Yang,et al.  Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants , 2010, Nature Genetics.

[43]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[44]  J. Whittaker,et al.  Molecular prenatal diagnosis: the impact of modern technologies , 2010, Prenatal diagnosis.

[45]  C. Bönnemann,et al.  Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations , 2010, Neuromuscular Disorders.

[46]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[47]  Christian Gilissen,et al.  Massively parallel sequencing of ataxia genes after array‐based enrichment , 2010, Human mutation.

[48]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[49]  T. Prior.  Perspectives and diagnostic considerations in spinal muscular atrophy , 2010, Genetics in Medicine.

[50]  K. Frazer,et al.  Microdroplet-based PCR amplification for large scale targeted sequencing , 2009, Nature Biotechnology.

[51]  Emily H Turner,et al.  Target-enrichment strategies for next-generation sequencing , 2010, Nature Methods.

[52]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[53]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[54]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[55]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[56]  J. Morris,et al.  TARDBP 3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy , 2009, Acta Neuropathologica.

[57]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[58]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[59]  Cole Trapnell,et al.  How to map billions of short reads onto genomes , 2009, Nature Biotechnology.

[60]  L. Hougs,et al.  Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives , 2009, Human mutation.

[61]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[62]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[63]  E. Aller,et al.  Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene , 2009, Human Genetics.

[64]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[65]  Matthew J. Huentelman,et al.  IDENTIFICATION OF GENETIC VARIANTS USING BARCODED MULTIPLEXED SEQUENCING , 2008, Nature Methods.

[66]  Steven M. Johnson,et al.  A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. , 2008, Genome research.

[67]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[68]  S. Salzberg,et al.  Bioinformatics challenges of new sequencing technology. , 2008, Trends in genetics : TIG.

[69]  R. Zimmern,et al.  The evaluation of genetic tests. , 2007, Journal of public health.

[70]  S. V. D. Maarel,et al.  Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy , 2006, Neuromuscular Disorders.

[71]  Thomas W Prior,et al.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.

[72]  S. Ennis,et al.  A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.

[73]  K. Pelin,et al.  Complete genomic structure of the human nebulin gene and identification of alternatively spliced transcripts , 2004, European Journal of Human Genetics.

[74]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[75]  L. Kunkel,et al.  Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction , 1990, Human Genetics.

[76]  D. Figarella-Branger,et al.  Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. , 2004, Archives of neurology.

[77]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[78]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[79]  M. Hill.  THE NEUROMUSCULAR JUNCTION DISORDERS , 2003, Journal of neurology, neurosurgery, and psychiatry.

[80]  S. Quake,et al.  Sequence information can be obtained from single DNA molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Provision of genetic services in Europe: current practices and issues , 2003, European Journal of Human Genetics.

[82]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[83]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[84]  S. Scherer,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[85]  C. Hayward,et al.  Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis , 1999, Neurology.

[86]  M. Schwartz.  Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. , 1999, Clinical chemistry.

[87]  N. Monnier,et al.  Identification of Heterozygous and Homozygous Individuals with the Novel RYR1 Mutation Cys35Arg in a Large Kindred , 1997, Anesthesiology.

[88]  M. Ronaghi,et al.  Real-time DNA sequencing using detection of pyrophosphate release. , 1996, Analytical biochemistry.

[89]  M. Phillips,et al.  The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. , 1996, Genomics.

[90]  H. Klamut,et al.  The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced , 1995, Nature Genetics.

[91]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[92]  J. Mandel,et al.  Two hot spots of recombination in the DMD gene correlate with the deletion prone regions. , 1992, Human molecular genetics.

[93]  C. Wijmenga,et al.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.

[94]  M. Bobrow,et al.  Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. , 1992, Journal of medical genetics.

[95]  A. Emery.  Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.

[96]  R A Gibbs,et al.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.